Abstract
Background
Vitiligo and acne vulgaris, commonly affecting the face, have significant psychological effects and impair the quality of life of the affected individuals. Because of their negative effect on physical appearance, these conditions may act as a potential barrier to social relationships and cause social anxiety.
Objective
The objective of the study was to investigate the social anxiety, quality of life, anxiety, and depression levels of acne and vitiligo patients with facial involvement and compare these levels with healthy controls.
Methods
Thirty-seven vitiligo and 37 acne patients, aged older than 18 years, with facial involvement and 74 age- and sex-matched healthy control subjects were included in the study. The patients and healthy controls were asked to complete the Liebowitz Social Anxiety Scale, the Hospital Anxiety and Depression Scale, and the Dermatology Life Quality Index. Disease severity was evaluated both objectively by the physician and subjectively by the patients using a visual analog scale.
Results
Social anxiety, depression, and anxiety levels of vitiligo and acne patients were significantly higher than healthy controls (p < 0.05). Quality of life was impaired in both patient groups (Dermatology Life Quality Index scores for vitiligo: 5.6 ± 5.1; acne: 6.4 ± 6.2). There was no correlation between psychiatric scale scores and disease severity. Quality of life was negatively correlated with social anxiety and depression levels in both patient groups in our study.
Conclusion
Vitiligo and acne patients had higher levels of social anxiety, anxiety, and depression compared with healthy control subjects. Considering that increased psychosocial morbidity was regardless of age, sex, and disease severity and was correlated with quality of life impairment, evaluation of the psychosocial morbidity, in particular social anxiety, may be valuable in all vitiligo and acne patients.
Similar content being viewed by others
References
Timms RM. Moderate acne as a potential barrier to social relationships: myth of reality? Psyhcol Health Med. 2013;18:310–20.
Ongenae K, Beelaert L, van Geel N, Naeyaert JM. Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol. 2006;20:1–8.
Kent G, al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol. 1996;21:330–3.
Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58–60.
Homan MWL, Spuls PI, de Korte J, Bos JD, Sprangers MA, van der Veen JP. The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol. 2009;61:411–20.
Ruscio AM, Brown TA, Chiu WT, Sareen J, Stein MB, Kessler RC. Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. Psychol Med. 2008;38:15–28.
Koyuncu A, Ertekin E, Deveci E, et al. Age of onset in social anxiety disorder: relation to clinical variables and major depression comorbidity. Ann Clin Psychiatry. 2015;27:84–9.
Stein MB, Stein DJ. Social anxiety disorder. Lancet. 2008;371:1115–25.
Brook CA, Schmidt LA. Social anxiety disorder: a review of environmental risk factors. Neuropsychiatr Dis Treat. 2008;4:123–43.
Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol. 2005;152:1165–72.
Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140:672–6.
Ahmed A, Leon A, Butler DC, Reichenberg J. Quality-of-life effects of common dermatological diseases. Semin Cutan Med Surg. 2013;32:101–9.
Yarpuz AY, Saadet ED, Sanli HE, Ozguven HD. Social anxiety level in acne vulgaris patients and its relationship to clinical variables. Turk Psikiyatri Derg. 2008;19:29–37.
Bez Y, Yesilova Y, Kaya MC, Sir A. High social phobia frequency and related disability in patients with acne vulgaris. Eur J Dermatol. 2011;21:756–60.
Loney T, Standage M, Lewis S. Not just ‘skin deep’: psychosocial effects of dermatological-related social anxiety in a sample of acne patients. J Heatlh Psychol. 2008;13:47–54.
Balaban OD, Atagun MI, Ozguven HD, Ozsan HH. Psychiatric morbidity in patients with vitiligo. Dusunen Adam. 2011;24:306–13.
Krüger C, Schallreuter KU. Stigmatisation, avoidance behaviour and difficulties in coping are common among adult patients with vitiligo. Acta Derm Venereol. 2015;95:553–8.
Hughes JE, Barraclough BM, Hamblin LG, White JE. Psychiatric symptoms in dermatology patients. Br J Psychiatry. 1983;143:51–4.
Picardi A, Abeni D, Renzi C, Braga M, Puddu P, Pasquini P. Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Derm Venereol. 2001;81:410–4.
Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(S1):1–29.
Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141–73.
Soykan C, Ozguven HD, Gencoz T. Liebowitz Social Anxiety Scale: the Turkish version. Psychol Rep. 2003;93:1059–69.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
Aydemir O, Guvenir T, Kuey L, Kultur S. Hastane anksiyete ve depresyon olçegi Turkce formunun gecerlilik ve guvenilirligi. Turk Psikiyatri Derg. 1997;8:280–7.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.
Oztürkcan S, Ermertcan AT, Eser E, Sahin MT. Cross validation of the Turkish version of Dermatology Life Quality Index. Int J Dermatol. 2006;45:1300–7.
Shah R, Hunt J, Webb TL, Thompson AR. Starting to develop self-help for social anxiety associated with vitiligo: using clinical significance to measure the potential effectiveness of enhanced psychological self-help. Br J Dermatol. 2014;171:332–7.
Khattri S, Bist JS, Arun A, Mehta AK. Clinical correlates of vitiligo with depression and anxiety: a comparative study in patients and their caregivers. Int J Adv Res. 2015;3:200–5.
Ozturk A, Deveci E, Bagcioglu E, Atalay F, Serdar Z. Anxiety, depression, social phobia, and quality of life in Turkish patients with acne and their relationships with the severity of acne. Turk J Med Sci. 2013;43:660–6.
Clark DM, Wells A. A cognitive model of social phobia. In: Heimberg RG, Liebowitz MR, Hope DA, Schenier FR, editors. Social phobia: diagnosis, assessment, and treatment. New York: Guilford Press; 1995. p. 69–74.
Yazici K, Baz K, Yazici AE, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol. 2004;18:435–9.
Kostopoulou P, Jouary T, Quintard B, et al. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol. 2009;161:128–33.
Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol. 2003;148:373–4.
Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol. 1998;134:454–8.
Wittkowski A, Richards HL, Griffiths CE, Main CJ. The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychosom Res. 2004;57:195–200.
Sampogna F, Picardi A, Chren MM, et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004;66:620–4.
Sampogna F, Raskovic D, Guerra L, et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol. 2008;159:351–9.
Ramakrishna P, Rajni T. Psychiatric morbidity and quality of life in vitiligo patients. Indian J Psychol Med. 2014;36:302–3.
Demircay Z, Seckin D, Senol A, Demir F. Patient’s perspective: an important issue not to be overlooked in assessing acne severity. Eur J Dermatol. 2008;18:181–4.
Magin PJ, Pond CD, Smith WT, Watson AB, Goode SM. Correlation and agreement of self-assessed and objective skin disease severity in a cross-sectional study of patients with acne, psoriasis, and atopic eczema. Int J Dermatol. 2011;50:1486–90.
Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003;4:833–42.
Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139:846–50.
Woodruff PW, Higgins EM, du Vivier AW, Wessely S. Psychiatric illness in patients referred to a dermatology-psychiatry clinic. Gen Hosp Psychiatry. 1997;19:29–35.
Kent G, Al’Abadie M. Psyshologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol. 1996;35:895–8.
Niemeier V, Kupfer J, Gieler U. Acne vulgaris-psychosomatic aspects. J Dtsch Dermatol Ges. 2006;4:1027–36.
Moretti S, Arunachalam M, Colucci R, et al. Autoimmune markers in vitiligo patients appear correlated with obsession and phobia. J Eur Acad Dermatol Venereol. 2012;26:861–7.
Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psyhiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002;16:573–8.
Stein MB, Kean YM. Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry. 2000;157:1606–13.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Andac Salman, Emel Kurt, Volkan Topcuoglu, and Zeynep Demircay have no conflict of interest.
Funding
No funding was received for the preparation of this review.
Rights and permissions
About this article
Cite this article
Salman, A., Kurt, E., Topcuoglu, V. et al. Social Anxiety and Quality of Life in Vitiligo and Acne Patients with Facial Involvement: A Cross-Sectional Controlled Study. Am J Clin Dermatol 17, 305–311 (2016). https://doi.org/10.1007/s40257-016-0172-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-016-0172-x